Dechert advised Ostium Group on the deal. Ostium Group, a medical deeptech specializing in innovative surgical instruments, completed its first fundraising led by Marle International Holding, Europe’s...
You must be a Standard 1 Year member to access this content.
Dechert advised Abivax on the deal. Abivax, a Euronext Paris listed clinical-stage biotechnology company, executed its oversubscribed capital increase of €60 million and convertible bonds of...
You must be a Standard 1 Year member to access this content.
Dechert and Villey Girard Grolleaud advised Affluent Medical on the deal. Affluent Medical, a French medtech company specialising in urology and cardiology, executed its IPO on the...
You must be a Standard 1 Year member to access this content.
